Literature DB >> 28436530

Solvent-free, uncatalyzed asymmetric "ene" reactions of N-tert-butylsulfinyl-3,3,3-trifluoroacetaldimines: a general approach to enantiomerically pure α-(trifluoromethyl)tryptamines.

Giuseppe Mazzeo1, Giovanna Longhi, Sergio Abbate, Martina Palomba, Luana Bagnoli, Francesca Marini, Claudio Santi, Jianlin Han, Vadim A Soloshonok, Emilio Di Crescenzo, Renzo Ruzziconi.   

Abstract

A novel approach to regioselectively substituted and stereoselectively α-trifluoromethylated tryptamines is reported based on the ene reaction of Boc-protected 3-methyleneindolines with optically pure (R)- or (S)-tert-butanesulfinyltrifluoroacetaldimine. Boc- and sulfinylamido-protected α-trifluoromethyltryptamines are obtained in 60-70% yield and 85/15 dr by just heating equimolar amounts of the two reaction partners at 80-90 °C for 2-3 h without a solvent. The absolute configuration of the amino α-carbon has been assigned based on the vibrational circular dichroism (VCD) spectral analysis. The two protecting group can be chemoselectively removed allowing further regio- and stereoselective elaboration of the ene products to various biologically interesting compounds.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28436530     DOI: 10.1039/c7ob00670e

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  2 in total

1.  Asymmetric Synthesis of Spirooxindoles via Nucleophilic Epoxidation Promoted by Bifunctional Organocatalysts.

Authors:  Martina Miceli; Andrea Mazziotta; Chiara Palumbo; Elia Roma; Eleonora Tosi; Giovanna Longhi; Sergio Abbate; Paolo Lupattelli; Giuseppe Mazzeo; Tecla Gasperi
Journal:  Molecules       Date:  2018-02-16       Impact factor: 4.411

2.  CF3: an overlooked chromophore in VCD spectra. A review of recent applications in structural determination.

Authors:  Sergio Abbate; Giovanna Longhi; Giuseppe Mazzeo; Claudio Villani; Silvija Petković; Renzo Ruzziconi
Journal:  RSC Adv       Date:  2019-04-16       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.